Fusion Pharmaceuticals lands $21 mln

Hamilton, Ontario-based Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company, has raised an additional $21 million in Series A funding, bringing the total tally to $46 million. The investors in this round included Adams Street Partners, Seroba Life Sciences and Varian Medical Systems Inc.

North AmericaUSBriefs